Is Repurposing Drugs the Way to Beat Covid? Maybe. Maybe not. An Expert Weighs In.

Simple item page
dc.contributor.authorSeley-Radtke, Katherine
dc.contributor.authorBloom, Josh
dc.date.accessioned2025-07-30T19:22:55Z
dc.date.issued2020-08-13
dc.description.abstractThere are both advantages and disadvantages of studying repurposed drugs to battle COVID-19. In an interview, ACSH advisor Dr. Kathie Seley-Radtke weighs in on this method while providing a glimpse at some of the very promising research now going on in her lab. If you want to know how antiviral drug discovery might tame COVID-19, this is a must-read.
dc.description.urihttps://www.acsh.org/news/2020/08/13/repurposing-drugs-way-beat-covid-maybe-maybe-not-expert-weighs-14968
dc.format.extent8 pages
dc.genrearticles
dc.identifierdoi:10.13016/m2ulao-7bag
dc.identifier.citationSeley-Radtke, Katherine, and Josh Bloom. “Is Repurposing Drugs the Way to Beat Covid? Maybe. Maybe Not. An Expert Weighs In.” American Council on Science and Health. August 13, 2020. https://www.acsh.org/news/2020/08/13/repurposing-drugs-way-beat-covid-maybe-maybe-not-expert-weighs-14968.
dc.identifier.urihttp://hdl.handle.net/11603/39622
dc.language.isoen_US
dc.publisherAmerican Council on Science and Health
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Chemistry & Biochemistry Department
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subjectantiviral drug
dc.subjectSARS-CoV-2
dc.subjectCOVID-19
dc.titleIs Repurposing Drugs the Way to Beat Covid? Maybe. Maybe not. An Expert Weighs In.
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-0154-3459

Files

Collections

UMBC Faculty Collection
UMBC Chemistry & Biochemistry Department